Jaguar Health, Inc. (JAGX) vs Vivos Therapeutics, Inc. (VVOS)
A side-by-side comparison of Jaguar Health, Inc. and Vivos Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
JAGX
Jaguar Health, Inc.
$5.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VVOS
Vivos Therapeutics, Inc.
$0.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — JAGX vs VVOS
growth of $100 · dividends reinvested · last 4yJAGX -100.0% (-87.8%/yr)VVOS -98.9% (-67.8%/yr)VVOS compounded faster over this window
Log scale — wide-divergence pair
JAGX VVOS
JAGX vs VVOS: by the numbers
- •JAGX is the larger company ($2M vs $2M market cap).
- •Both run net losses; VVOS's is the smaller (-122.42% vs -131.76% net margin).
- •JAGX grew revenue faster over the past five years (31.88% vs 7.52% CAGR).
Metrics side by side
Valuation
| Metric | JAGX | VVOS |
|---|---|---|
| P/S ratio | 0.09 | 0.10 |
| P/B ratio | 0.37 | N/A |
Profitability
| Metric | JAGX | VVOS |
|---|---|---|
| Gross margin | 67.21% | 59.72% |
| Operating margin | -391.87% | -107.92% |
| Net margin | -131.76% | -122.42% |
| ROE | -554.01% | N/A |
| ROIC | -110.81% | -182.30% |
Growth (annualized)
| Metric | JAGX | VVOS |
|---|---|---|
| Revenue CAGR (5Y) | 31.88% | 7.52% |
| Total return CAGR (5Y) | N/A | -72.60% |
Frequently asked
- Which has grown faster, JAGX or VVOS?
- Over the past five years, JAGX grew revenue faster — JAGX at a 31.88% CAGR versus VVOS at 7.52%.
Go deeper
Dig into the metrics
Jaguar Health ROEVivos Therapeutics ROEJaguar Health operating marginVivos Therapeutics operating marginJaguar Health revenue growthVivos Therapeutics revenue growthJaguar Health free cash flowVivos Therapeutics free cash flow
Jaguar Health & Vivos Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.